Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

FDA & EMA

FDA ODAC Backs Truqap Combination for PTEN-Deficient Metastatic Prostate Cancer

Clinical Trials

Social Media Misinformation Drives Over 16 Million Americans Toward High Skin Cancer Risk

ONCOLife

Restoring Proteostasis May Boost T Cell Function and Open a New Route for Immunotherapy

Clinical Trials

Phase 3 MagnetisMM-5 Trial Supports Earlier Use of Elranatamab in Relapsed Myeloma

ONCOLife

Real-World Analysis Links Community Oncology Care to Longer Survival in Multi-Cancer

ONCOLife

Early CAR T-Cell Intervention Shows Disease-Eradication Potential in High-Risk Myeloma

ONCOLife

PLN-101095 Plus Pembrolizumab Shows Durable Responses in ICI-R Solid Tumors

ONCOLife Issues

Featured Articles

AI-Assisted Zeta Navigation System Gains FDA Clearance for Brain Tumor Biopsy and Neurosurgery

3 May 2026

The Zeta Navigation System has received FDA 510(k) clearance alongside the Zeta Stylet and Zeta Bolt, expanding real-time, AI-assisted image guidance for neurosurgery. The platform may improve access to millimeter-level navigation for brain tumor biopsies...

Trending Articles

FDA Grants Priority Review to Ifinatamab Deruxtecan in Pretreated ES-SC Lung Cancer

MD Anderson Study Identifies DPY30 as Therapeutic Target in Pancreatic Cancer

ONCOLife

11 April 2026

Blocking DHODH Helps Triple Combination Overcome Resistance in Lung Cancer

ONCOLife

10 April 2026

New Strategy Blocks NMD, Unmasks Hidden Tumor Antigens, and Boosts Immunotherapy

ONCOLife

10 April 2026

Neladalkib Reaches FDA Review for TKI-Pretreated ALK+ Non-Small Cell Lung Cancer

FDA & EMA

9 April 2026

New Radio-Theranostic Promises to Broaden Targeted Radiation in Solid Tumors

FDA Grants Breakthrough Status to WU-CART-007 for T-Cell Leukemias and Lymphomas

FDA & EMA

1 April 2026

New IHC Biomarker Test Predicts Which Gastric Cancer Patients Benefit from Immunotherapy

ONCOLife

30 March 2026

Nonviral Gene Delivery Platform Offers Promise for Cancer Treatment and Cell Therapy

ONCOLife

30 March 2026

Immunotherapy Boosts Chemo Cutting Recurrence Risk by 50% in Colon Cancer

ONCOLife

30 March 2026

AI Predicts Chemotherapy Benefit in Breast Cancer Using Routine Pathology Slides

FDA Approves Agilent’s PD-L1 Test to Guide KEYTRUDA Use in Esophageal and GEJ Carcinoma

FDA & EMA

28 March 2026

Light-Activated Copper Nanoparticles Trigger Cuproptosis in Drug-Resistant Cancer Cells

ONCOLife

27 March 2026

New Protein Modification Linked to IDH-Mutant Cancers Opens Therapeutic Possibilities

ONCOLife

26 March 2026

BioNTech Showcases Promising Bispecific and ADC Data in Lung Cancer at ELCC 2026

ONCOLife

25 March 2026